Epirus Biopharmaceuticals Inc Stock Nasdaq
Equities
US29428P1075
Biotechnology & Medical Research
Sales 2014 | 0 0.01 | Sales 2015 | 0.7 0.96 | Capitalization | 75.33M 103M |
---|---|---|---|---|---|
Net income 2014 | -41M -56.09M | Net income 2015 | -52M -71.14M | EV / Sales 2014 | 14,770,294,750 x |
Net cash position 2014 | 14.18M 19.4M | Net cash position 2015 | 16.68M 22.82M | EV / Sales 2015 | 83,658,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+25.64% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.06% | 12.09B | |
+0.19% | 11.88B | |
-1.24% | 11.8B |